Literature DB >> 24970465

Interferon-γ release assay for the diagnosis of latent Mycobacterium tuberculosis infection in children younger than 5 years: a meta-analysis.

Long Ge1, Ji-Chun Ma1, Min Han1, Jin-Long Li1, Jin-Hui Tian2.   

Abstract

BACKGROUND: Interferon-γ release assays (IGRAs) have been widely used for the diagnosis of latent and active tuberculosis in adults, but their role in diagnosing latent tuberculosis infection (LTBI) in children younger than 5 years remains unclear.
OBJECTIVE: To evaluate the diagnostic performance of IGRAs for LTBI in children younger than 5 years.
METHODS: We searched the PubMed, EMBASE, Cochrane Library, and Web of Knowledge databases. According to inclusion criteria, the diagnostic studies of IGRAs for LTBI in children younger than 5 years were included. The study quality was assessed using the 14-item Quality Assessment of Diagnostic Accuracy Studies instrument. The Meta-Analyst software was used to analyze the data.
RESULTS: Seven studies (627 patients) were included. Meta-analysis showed that compared with tuberculin skin test (TST), the pooled sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR), positive predictive value (PPV), negative predictive value (NPV), accuracy and diagnosis odds ratio (DOR), and summary receiver operating characteristic (SROC) curve of QuantiFERON-TB (values in parentheses are 95% confidence intervals) were 0.841 (0.733-0.911), 0.895 (0.861-0.922), 8.046 (5.953-10.876), 0.192 (0.113-0.326), 0.622 (0.527-0.709), 0.970 (0.946-0.983), 0.891 (0.861-0.916), 50.718 (24.201-106.287), and 0.809 respectively. The pooled Sen, Spe, PLR, NLR, PPV, NPV, accuracy, DOR, and SROC curve of T-SPOT.TB test were 0.931 (0.760-0.983), 0.767 (0.684-0.833), 3.947 (2.854-5.459), 0.095 (0.026-0.354), 0.523 (0.398-0.645), 0.977 (0.914-0.994), 0.806 (0.737-0.860), 65.270 (13.463-316.434), and 0.855, respectively.
CONCLUSION: This meta-analysis showed that the sensitivity and specificity of IGRAs were slightly higher than TST and can be used as supporting tools to detect LTBI in children younger than 5 years. The methodological quality of diagnostic test needs to be improved.
© The Author(s) 2014.

Entities:  

Keywords:  children; interferon-γ release assay; latent Mycobacterium tuberculosis infection; meta-analysis

Mesh:

Year:  2014        PMID: 24970465     DOI: 10.1177/0009922814540040

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  6 in total

1.  [Thoracic manifestation of tuberculosis].

Authors:  D Kienzl-Palma; H Prosch
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

2.  Comparison study of QuantiFERON test with tuberculin skin testing to diagnose latent tuberculosis infection among nurses working in teaching hospitals of Ahvaz, Iran.

Authors:  Shokrollah Salmanzadeh; Hajar Abbasissifar; Seyed Mohmmad Alavi
Journal:  Caspian J Intern Med       Date:  2016

Review 3.  Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.

Authors:  Kai Ling Chin; Fadhilah Zulkipli Anis; Maria E Sarmiento; Mohd Nor Norazmi; Armando Acosta
Journal:  J Immunol Res       Date:  2017-06-20       Impact factor: 4.818

4.  Tuberculous peritonitis in children: Two case reports highlighting the important role of imaging.

Authors:  Jacob Zaslavsky; Lakeisha Mulugeta-Gordon; Irene Vasko; Thomas Presenza; Emily Scattergood; Debrah Meislich; Pauline Germaine
Journal:  Radiol Case Rep       Date:  2018-06-30

Review 5.  Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population.

Authors:  Ying Yang; Hong-Jiao Wang; Wei-Lin Hu; Guan-Nan Bai; Chun-Zhen Hua
Journal:  Diagnostics (Basel)       Date:  2022-02-10

6.  Improving pediatric TB diagnosis in North Kivu (DR Congo), focusing on a clinical algorithm including targeted Xpert MTB/RIF on gastric aspirates.

Authors:  Daan Van Brusselen; Erica Simons; Tony Luendo; Delphine Habarugira; Jimmy Ngowa; Nadine Neema Mitutso; Zakari Moluh; Mieke Steenssens; Rachelle Seguin; Hilde Vochten; Lucien Ngabo; Petros Isaakidis; Gabriella Ferlazzo
Journal:  Confl Health       Date:  2020-05-14       Impact factor: 2.723

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.